The spate of deaths have taken place in Kutch, Gujarat in west India in recent weeks, with alarm bells sounding after a 42 ...

The U.S. Food and Drug Administration (FDA) has granted approval of 5 new prescription medications that are labeled for use ...

Everything has a reason and is a phenomenon, according to science, and a true science student can never find it hard to know ...

According to the findings, a significant reduction in seizure frequency in DEE patients treated with bexicaserin was reported ...

CF33-hNIS has gained FDA orphan drug designation for the treatment of cholangiocarcinoma and is currently being evaluated in ...

With pivotal trial results and an approval from the FDA, the landscape is changing for patients with small cell lung cancer.

Immunosuppressants used in adeno-associated virus (AAV) gene therapy for monogenic disorders present an adverse effect ...

The ready-to-use formulation of bortezomib is now an FDA-approved option for patients with multiple myeloma and mantle cell ...

Serious adverse reactions (pyrexia and post-procedural hematoma) were reported in 2 patients in the Thrombin-JMI group. The effect of repeat exposure was evaluated in a prospective, double-blinded ...

The most common adverse events were infections, vomiting, pyrexia, somnolence and constipation, the biotech said. “When comparing to the baseline rates, patients in EMBOLD had over 2,000 fewer ...

The most common adverse reactions (≥30%) in patients who received KIMMTRAK were cytokine release syndrome, rash, pyrexia, pruritus, fatigue, nausea, chills, abdominal pain, edema, hypotension, dry ...

Positive opinion granted for KEYTRUDA plus chemotherapy for the first-line treatment of adult patients with primary advanced or recurrent endometrial carcinoma who are candidates for systemic therapy, ...